November 7, 2016 / 9:47 PM / 9 months ago

BRIEF-Arena Pharmaceuticals reports Q3 loss per share $0.05

Nov 7 (Reuters) - Arena Pharmaceuticals Inc

* Arena Pharmaceuticals reports third quarter 2016 financial results and provides corporate update

* Q3 revenue $19.2 million

* Q3 revenue view $14 million -- Thomson Reuters I/B/E/S

* Q3 loss per share $0.05

* Q3 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below